Tiantai Pharm. successfully passed USFDA inspection

From 21^st to 25^th October 2013, Tiantai Pharm received five-day USFDA on-site inspection concerning the antibiotic drugs of Clindamycin Hydrochloride and Clindamycin Phosphate. By means of documents review and going through the factory as well as follow-up corrective action every day after inspection, finally Tiantai Pharm passed USFDA inspection without any 483 defect, achieving a satisfactory result.